Review Update

 

TIDMMDX 
 
RNS Number : 9595M 
Meldex International PLC 
06 February 2009 
 

 
 
 
 
 
For Immediate Release 6 February 2009 
 
 
Meldex International Plc ("Meldex " or "the Company") 
 
 
Review Update 
 
 
Cambridge, UK, 6 February, 2009: Meldex International Plc (AIM: MDX), the 
directors report the following progress on their review of the Company's 
business activities. 
 
 
Appointment of NOMAD 
The directors are in discussions with potential NOMADs with a view to an 
appointment on or prior to 16 February 2009. However, there can be no assurance 
that such an appointment will be made on time or at all. 
 
 
Ostomy Patent 
On appeal by Hollister at a hearing of the Appeal Board of the European Patent 
Office, at which the Company made no representation, the Company's Patent No 0 
833 596 was revoked. The decision of the Appeal Board is final and no further 
appeal is permitted, therefore the Company will take no further action in the 
matter. Prior to the appeal being held the Company's former Chairman made the 
decision not to be represented at the appeal hearing. 
 
 
Melbrosin GmbH 
The Company is the largest creditor of Melbrosin GmbH and a claim is being 
prepared for submission to the Administrators, this claim will be submitted 
early in March 2009 as requested by the Administrators. 
 
 
Melbrosin Austria 
The Company has requested the directors of Melbrosin Austria to apply for an 
administrator to be appointed. An initial meeting with a potential administrator 
has been held and an application submitted to the relevant authority. 
 
 
Development Programme 
The directors have met with an independent specialist pharmaceutical company 
with a view to having certain of its portfolio of Rx and OTC dossiers reviewed 
for commercial potential. The Company will report the results of this exercise 
when received. 
 
 
A further update will be made on or before 13 February 2009. 
 
 
For information contact: 
Gary Cressman+44 (0) 1223 394 250 
Meldex International plc 
 
 
Barry Muncaster+44 (0) 1223 394 250 
Meldex International plc 
[e-mail] 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 MSCSSMFIMSUSEIE